Stay updated on Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial

Sign up to get notified when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Enrollment status on the study page has shifted to Terminated, indicating no further enrollment. The update also adds NIH grant/contract information and new date entries while removing the Recruiting indicator and the disease term Multiple myeloma from the visible content.
    Difference
    0.2%
    Check dated 2026-08-25T19:59:41.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The study's locations section has been expanded with numerous new sites across multiple countries, replacing the previous site count. This broadens where participants can enroll and reflects a larger geographic footprint.
    Difference
    14%
    Check dated 2026-08-18T18:31:05.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.6.5 has been added to the page, and Revision: v3.6.4 has been removed. This reflects a minor update to the page's revision history rather than content changes.
    Difference
    0.0%
    Check dated 2026-08-11T15:57:29.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The page now explicitly lists multiple myeloma as a disease topic and adds MedlinePlus Genetics as a related topic.
    Difference
    0.1%
    Check dated 2026-08-04T06:49:01.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page revision updated from v3.6.3 to v3.6.4, indicating a small internal update to the page version.
    Difference
    0.0%
    Check dated 2026-07-28T05:36:36.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page no longer displays the disease term 'Multiple myeloma' and the related topics link, reducing explicit disease context and associated educational resources. This changes how the study’s focus and related informational content are presented to users.
    Difference
    0.1%
    Check dated 2026-07-21T01:43:27.000Z thumbnail image

Stay in the know with updates to Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab Combo vs Daratumumab Combo in MM Clinical Trial page.